Pharmacists in Prince Frederick, Maryland
33 Pharmacists found in Prince Frederick
Mrs. Amy Christine Bolger, PHARM D
Pharmacist
80 W Dares Beach Rd, Prince Frederick, MD 20678
410-414-7404 410-414-7408
Awatif Zine El Abidine, PHARMACIST
Pharmacist
355 Market Square Dr, Prince Frederick, MD 20678
410-535-5313
Christiane Matagne Ngassam
Pharmacist - Pharmacotherapy
110 Hospital Rd Ste 100, Prince Frederick, MD 20678
410-535-3838
Constance Mafor Tazem
Pharmacist
150 Solomons Island Rd N, Prince Frederick, MD 20678
301-221-0326 410-535-6590
Dr. Donna Lynn Deninno, PHARM D
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
100 Hospital Dr, Calvert Memorial Hospital Pharmacy, Prince Frederick, MD 20678
410-535-8305 410-535-8307
Dr. Evelyn Theres Johnson, PHARMD, RPH
Pharmacist
355 Market Square Dr, Prince Frederick, MD 20678
410-535-5313
Janiffer L Gomes, PHARMD
Pharmacist
655 Solomons Island Rd N, Prince Frederick, MD 20678
410-535-5974
Dr. Jean Marie Fanba
Pharmacist
355 Market Square Dr, Prince Frederick, MD 20678
410-535-5313 410-535-5762
Mr. John Raymond Macintosh
Pharmacist
655 Solomons Island Rd N, Prince Frederick, MD 20678
410-535-5974 410-535-5785
Dr. Kanayo Ekeada, PHARMD
Pharmacist
110 Hospital Rd, Suite 100, Prince Frederick, MD 20678
410-535-3838
Dr. Kara A Harrer, PHARMD
Pharmacist - Pharmacotherapy
100 Hospital Rd, Prince Frederick, MD 20678
410-535-4000
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.